A systematic review and meta-analysis confirmed the prognostic benefit of CD8+ T cell infiltration in HNSCC patients and found that FoxP3+ TIL contributed to improve OS [47]. The gene discussed is FOXP3; the disease is head and neck squamous cell carcinoma.